Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 8:16 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 961–984 of 2,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Neurodevelopmental Disorder Clear all

Conditions: Autism Spectrum Disorder, Cerebral Palsy
Interventions: Hippotherapy; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 6 Years to 17 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: ADHD
Interventions: CLONICEL (clonidine HCl sustained release), Placebo; Drug
Lead sponsor: Addrenex Pharmaceuticals, Inc.; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 198 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 23
States / cities: Little Rock, Arkansas • El Centro, California • Irvine, California + 18 more

Conditions: Attention Deficit Disorder With Hyperactivity
Interventions: Tai Chi training; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 23 Years
Enrollment: 161 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Intellectual Disability, Variable
Interventions: Pre-Dental Telehealth (PDT); Behavioral
Lead sponsor: Boston University; Other
Eligibility: 12 Years to 18 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Autism, Asperger's Syndrome, Pervasive Developmental Disorder Not Otherwise Specified, Generalized Anxiety Disorder, Social Phobia, Separation Anxiety Disorder, Obsessive-compulsive Disorder
Interventions: Cognitive Behavioral Therapy, Treatment as usual; Other
Lead sponsor: University of South Florida; Other
Eligibility: 11 Years to 16 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: St. Petersburg, Florida

Conditions: Autistic Disorder
Interventions: N-Acetyl Cysteine, Placebo - sugar pill; Drug · Other
Lead sponsor: Stanford University; Other
Eligibility: 3 Years to 12 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Stanford, California

Conditions: Rett Syndrome
Interventions: Recombinant Human Insulin Growth Factor 1 (rhIGF-1), Placebo; Drug
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 2 Years to 10 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Attention Deficit Disorder With Hyperactivity
Interventions: Not listed
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 5 Years to 13 Years
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Attention Deficit Disorder With Hyperactivity
Interventions: Psychosocial (behavioral) Intervention; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 7 Years to 11 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Developmental Disabilities, Feeding Disorder
Interventions: Not listed
Lead sponsor: Société des Produits Nestlé (SPN); Industry
Eligibility: 13 Months to 17 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Hollywood, Florida

Conditions: Behavior and Behavior Mechanisms
Interventions: Demand Informed Moderator Analysis; Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 86 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 5
States / cities: Gallatin, Tennessee • Lebanon, Tennessee • Murfreesboro, Tennessee + 2 more

Conditions: Autism Spectrum Disorder, Anxiety
Interventions: Sertraline, CBT/BIACA, Placebo; Drug · Behavioral
Lead sponsor: University of California, Davis; Other
Eligibility: 8 Years to 14 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Autism Spectrum Disorder, Language Development, Literacy
Interventions: Structural vs. Random sequences of stimuli, Intact vs. Degraded speech, Repeating 5-syllable nonwords or 2-syllable nonwords, Recall letter or syllable strings that either contain highly frequent bigram/trigram items or infrequent items according to English Corpus data.; Behavioral
Lead sponsor: Northeastern University; Other
Eligibility: 72 Months to 90 Months
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: CONCERTA (methylphenidate HCl) or placebo; Drug
Lead sponsor: Ortho-McNeil Janssen Scientific Affairs, LLC; Industry
Eligibility: 9 Years to 12 Years
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 3
States / cities: Little Rock, Arkansas • Las Vegas, Nevada • Durham, North Carolina

Conditions: Aggression, Attention Deficit-Hyperactivity, Oppositional Defiant Disorder, Pervasive Development Disorders, Bipolar Disorder
Interventions: risperidone, olanzapine, aripiprazole; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 6 Years to 18 Years
Enrollment: 144 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Vayarin®, Placebo; Other
Lead sponsor: Enzymotec; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 171 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 4
States / cities: Marietta, Georgia • Mount Kisco, New York • New York, New York

Conditions: Childhood-Onset Fluency Disorder
Interventions: NOE-105, Placebo; Drug
Lead sponsor: Noema Pharma AG; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 6
States / cities: Bellflower, California • Jacksonville, Florida • Orlando, Florida + 3 more

Conditions: Anxiety Disorders, Stress Disorders, Post-Traumatic, Pregnancy, High Risk, Depressive Disorder, Major, Pregnancy Complications, ADHD - Attention Deficit Disorder With Hyperactivity
Interventions: Collaborative Mental Health Care Program (CMHCP); Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 100 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Anxiety, Autism Spectrum Disorder
Interventions: Not listed
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 36 Months to 71 Months
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Attention Deficit Disorder With Hyperactivity
Interventions: Methylphenidate; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 3 Years to 5 Years
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2006
U.S. locations: 6
States / cities: Irvine, California • Los Angeles, California • Baltimore, Maryland + 2 more

Conditions: Intellectual and Developmental Disabilities
Interventions: Always Uniquely Me mobile phone application; Other
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New Hyde Park, New York

Conditions: Autism, Children
Interventions: Not listed
Lead sponsor: Le Bonheur Children's Hospital; Other
Eligibility: 4 Years to 17 Years
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Intellectual Disability
Interventions: Genomic sequencing and molecular diagnostic results, if any., EHR-Based Network Model; Genetic · Other
Lead sponsor: Rady Pediatric Genomics & Systems Medicine Institute; Other
Eligibility: 7 Years to 17 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: San Diego, California

Conditions: Sensory Processing Dysfunction
Interventions: Not listed
Lead sponsor: The Spiral Foundation at OTA Watertown; Other
Eligibility: 13 Years to 95 Years
Enrollment: 1,300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Newton, Massachusetts

Search by objective public record fields.

Upper Extremity Function Before and After Hippotherapy in Children With Autism Spectrum Disorder and/or Cerebral Palsy

CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD

Psychological Effects of Tai Chi Training

A Pilot Project to Facilitate Dental Care and Reduce Barriers For Youth With Disabilities

Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism

A Study of N-Acetyl Cysteine in Children With Autism

Treatment of Rett Syndrome With Recombinant Human IGF-1

Nutrient Intake in Children With Attention Deficit Hyperactivity Disorder

Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I

Tube Feeding Tolerance After Switch to Peptide Based Formula in Children With Developmental Delay

Translational Research to Inform Interventions for Challenging Behavior

Specifying and Treating Anxiety in Autism Research

Predicting Language and Literacy Growth in Children With ASD Using Statistical Learning

CONCERTA Lab School Study

Metabolic Effects of Antipsychotics in Children

Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)

A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus)

MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal Patients

Phenomenology of Anxiety in Preschool Children With ASD

Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)

Use of a Digital Snapshot to Reduce Use of Restraints During Emergency Department Visits and Improve Experience of Care for PWIDD

Biomarker of Children With Familial Autoimmune History

Mental Health Crises in Youth With IDDs

Sensory Processing Difficulties in Adults and Adolescents